Your browser doesn't support javascript.
loading
Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy.
Li, Zhanguo; Zhang, Fengchun; Kay, Jonathan; Fei, Kaiyin; Han, Chenglong; Zhuang, Yanli; Wu, Zhong; Hsia, Elizabeth C.
Affiliation
  • Li Z; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Zhang F; Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Beijing, China.
  • Kay J; Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School and UMass Memorial Medical Center, Worcester, Massachusetts, USA.
  • Fei K; Immunology, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Han C; Patient-Reported Outcomes, Janssen Global Services, Malvern, Pennsylvania, USA.
  • Zhuang Y; Biologics Clinical Pharmacology, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Wu Z; Clinical Biostatistics, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Hsia EC; Immunology, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
Int J Rheum Dis ; 19(11): 1143-1156, 2016 Nov.
Article in En | MEDLINE | ID: mdl-26259617
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Methotrexate / Antirheumatic Agents / Antibodies, Monoclonal Type of study: Clinical_trials / Diagnostic_studies Aspects: Patient_preference Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Int J Rheum Dis Journal subject: REUMATOLOGIA Year: 2016 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Methotrexate / Antirheumatic Agents / Antibodies, Monoclonal Type of study: Clinical_trials / Diagnostic_studies Aspects: Patient_preference Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Int J Rheum Dis Journal subject: REUMATOLOGIA Year: 2016 Document type: Article Affiliation country: China